PhaseBio Pharmaceuticals Inc PHAS:NASDAQ

Last Price$10.52NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/24/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$9.51 (1)
Ask (Size)$10.59 (3)
Day Low / HighN/A - N/A
Volume126.8 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 05/24/2019


PhaseBio Pharmaceuticals Inc ( NASDAQ )

Price: $10.52
Change: +0.65 (6.59%)
Volume: 126.8 K
4:00PM ET 5/24/2019

Xeris Pharmaceuticals Inc ( NASDAQ )

Price: $11.37
Change: -0.35 (2.99%)
Volume: 130.7 K
4:00PM ET 5/24/2019

Dova Pharmaceuticals Inc ( NASDAQ )

Price: $9.94
Change: +0.01 (0.10%)
Volume: 103.3 K
3:59PM ET 5/24/2019

Beyondspring Inc ( NASDAQ )

Price: $14.51
Change: +0.01 (0.07%)
Volume: 9.8 K
4:00PM ET 5/24/2019

Constellation Pharmaceuticals Inc ( NASDAQ )

Price: $10.53
Change: -0.01 (0.09%)
Volume: 23.7 K
3:59PM ET 5/24/2019

Read more news Recent News

MTNewswires After-Hours News Movers
5:42PM ET 4/16/2019 MT Newswires

Some of the stocks moving on news-driven events in Tuesday's after-hours include: SQBG, +22.81% SFS, +18.92% ADVM, +6.90% SELB, +5.58% CSX, +4.56% UAL,...

PhaseBio Pharmaceuticals Raises $49.5 Mln from Public Offering of Common Shares
4:10PM ET 4/16/2019 MT Newswires

PhaseBio Pharmaceuticals (PHAS) said Tuesday that it has closed its underwritten public offering of about 4.1 million common shares, including the full...

PhaseBio Prices $43.0 Mln Common Stock Offering
3:48AM ET 4/12/2019 MT Newswires

PhaseBio Pharmaceuticals (PHAS) priced an underwritten public offering of 3,586,500 common shares at $12.00 per share on Thursday for expected gross...

After Hours Watch List Scorecard: IZEA, PHAS, PTE
5:20PM ET 4/10/2019 MT Newswires

Here's how the stocks on Tuesday's After Hours Watch List performed during today's regular session AFTER HOURS REGULAR SESSION IZEA ...

Company Profile

Business DescriptionPhaseBio Pharmaceuticals, Inc. is engaged in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA. View company web site for more details
Address1 Great Valley Parkway
Malvern, Pennsylvania 19355
Number of Employees24
Recent SEC Filing05/24/20194
Chief Executive Officer & DirectorJonathan P. Mow
Chief Financial OfficerJohn P. Sharp
Chief Medical OfficerJohn S. Lee
Vice President-Research & Scientific AffairsJames Ballance

Company Highlights

Price Open$9.97
Previous Close$9.87
52 Week Range$2.55 - 16.65
Market Capitalization$257.7 M
Shares Outstanding24.5 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/08/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.16
Beta vs. S&P 500N/A
Net Profit Margin-10,403.11%
Return on Equity-124.71%

Analyst Ratings as of 05/17/2019

Consensus RecommendationConsensus Icon
Powered by Factset